These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3580445)

  • 41. Correlation between acetylator phenotypes and genotypes of polymorphic arylamine N-acetyltransferase in human liver.
    Deguchi T; Mashimo M; Suzuki T
    J Biol Chem; 1990 Aug; 265(22):12757-60. PubMed ID: 2376572
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Survey of the human acetylator polymorphism in spontaneous disorders.
    Evans DA
    J Med Genet; 1984 Aug; 21(4):243-53. PubMed ID: 6387123
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Arylamine N-acetyltransferases and drug response.
    Meisel P
    Pharmacogenomics; 2002 May; 3(3):349-66. PubMed ID: 12052143
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacogenetically hazardous drugs: a proposed new scoring method.
    Szórády I; Sánta A
    Acta Physiol Hung; 1991; 77(3-4):305-18. PubMed ID: 1755332
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification and inheritance of inbred hamster N-acetyltransferase isozymes in peripheral blood.
    Hein DW; Kirlin WG; Ferguson RJ; Thompson LK; Ogolla F
    J Pharmacol Exp Ther; 1986 Dec; 239(3):823-8. PubMed ID: 3491898
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human acetylator polymorphism: estimate of allele frequency in Libya and details of global distribution.
    Karim AK; Elfellah MS; Evans DA
    J Med Genet; 1981 Oct; 18(5):325-30. PubMed ID: 7328611
    [TBL] [Abstract][Full Text] [Related]  

  • 47. N-acetylator phenotypes in hyperthyroidism.
    Siegmund W; Franke G; Meng S; Gothe P; Meng W
    Int J Clin Pharmacol Ther Toxicol; 1988 Aug; 26(8):397-9. PubMed ID: 3220615
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A simple pharmacokinetic method for separating the three acetylation phenotypes: a preliminary report.
    Lee EJ; Lee LK
    Br J Clin Pharmacol; 1982 Mar; 13(3):375-8. PubMed ID: 7059437
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Induction of acetylation in rats by pharmacological agents].
    Riazanov EM; Tret'iakov AV; Aleksandrov VA
    Vopr Med Khim; 1985; 31(5):112-4. PubMed ID: 4090354
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Possible optimization of sulphadimidine dosage for acetylator phenotyping.
    Hombhanje F
    Jpn J Pharmacol; 1991 Aug; 56(4):531-4. PubMed ID: 1744992
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacogenomics of arylamine N-acetyltransferases--from drug metabolism to drug discovery.
    Sim E
    Pharmacogenomics; 2002 Nov; 3(6):729-31. PubMed ID: 12437474
    [No Abstract]   [Full Text] [Related]  

  • 52. Pharmacogenetics and its clinical implications: N-acetylation polymorphism.
    Horai Y; Ishizaki T
    Ration Drug Ther; 1987 Oct; 21(10):1-7. PubMed ID: 3326026
    [No Abstract]   [Full Text] [Related]  

  • 53. [Acetylation phenotype in patients with periodic disease].
    Podymov VK; Vinogradova OM; Kovaleva VL; Kochubeĭ LN; Galstian SM
    Ter Arkh; 1988; 60(6):95-8. PubMed ID: 3206381
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship between acetylator phenotype and intensity of the hypoglycaemic effect of a suplhonamide preparation in children with insulin-dependent diabetes.
    Hadasová E; Brysová V; Utĕsený J; Macků M
    Bratisl Lek Listy; 1991 Dec; 92(12):609-14. PubMed ID: 1806177
    [TBL] [Abstract][Full Text] [Related]  

  • 55. N-acetyltransferase phenotypes in bladder tumour patients with and without carcinoma in situ in selected site biopsies.
    Mommsen S; Wolf H
    Scand J Urol Nephrol; 1985; 19(3):203-4. PubMed ID: 4070990
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acetylation phenotype status in a Bangladeshi population and its comparison with that of other Asian population data.
    Zaid RB; Nargis M; Neelotpol S; Hannan JM; Islam S; Akhter R; Ali L; Azad Khan AK
    Biopharm Drug Dispos; 2004 Sep; 25(6):237-41. PubMed ID: 15334622
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acetylator polymorphism in Parkinson's disease.
    Ladero JM; Jimenez FJ; Benitez J; Fernandez-Gundin MJ; Martinez C; Llerena A; Cobaleda J; Muñoz JJ
    Eur J Clin Pharmacol; 1989; 37(4):391-3. PubMed ID: 2598972
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Importance of acetylator phenotype in the identity of Asian populations.
    Zaid RB; Nargis M; Neelotpol S; Sayeed MA; Banu A; Shurovi S; Hassan KN; Salimullah M; Ali L; Azad Khan AK
    Hum Biol; 2007 Jun; 79(3):363-8. PubMed ID: 18078208
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interindividual and intraindividual variability in acetylation: characterization with caffeine.
    Hardy BG; Lemieux C; Walker SE; Bartle WR
    Clin Pharmacol Ther; 1988 Aug; 44(2):152-7. PubMed ID: 3396262
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lack of relevance of the acetylator status on dapsone response in chronic autoimmune thrombocytopenic purpura.
    Le Louët H; Ruivart M; Bierling P; Duche JC; Godeau B
    Am J Hematol; 1999 Dec; 62(4):251-2. PubMed ID: 10589083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.